Measurement of immunoglobulin free light chains (FLC) as a therapeutic biomarker in the treatment of rheumatoid arthritis patients with anti-CD20 antibodies

F.A.M. Redegeld; T. Groot Kormelink; F.P.J.G. Lafeber; J.A.G. van Roon

Measurement of immunoglobulin free light chains (FLC) as a therapeutic biomarker in the treatment of rheumatoid arthritis patients with anti-CD20 antibodies

F.A.M. Redegeld (Inventor), T. Groot Kormelink (Inventor), F.P.J.G. Lafeber (Inventor), J.A.G. van Roon (Inventor)

Dept of Pharmaceutical Sciences

University Medical Center Utrecht

Research output: Patent › Other research output

Original language	Undefined/Unknown
Patent number	61/238694
Publication status	Published - 1 Sept 2009

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Farmacie(FARM)
Biomedische technologie en medicijnen
Immunology
Pharmacology
Overig medisch onderzoek

Cite this

@misc{a60b508485254166b025108c19da3658,

title = "Measurement of immunoglobulin free light chains (FLC) as a therapeutic biomarker in the treatment of rheumatoid arthritis patients with anti-CD20 antibodies",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Farmacie(FARM), Biomedische technologie en medicijnen, Immunology, Pharmacology, Overig medisch onderzoek",

author = "F.A.M. Redegeld and {Groot Kormelink}, T. and F.P.J.G. Lafeber and {van Roon}, J.A.G.",

year = "2009",

month = sep,

day = "1",

language = "Undefined/Unknown",

type = "Patent",

note = "61/238694",

}

TY - PAT

T1 - Measurement of immunoglobulin free light chains (FLC) as a therapeutic biomarker in the treatment of rheumatoid arthritis patients with anti-CD20 antibodies

AU - Redegeld, F.A.M.

AU - Groot Kormelink, T.

AU - Lafeber, F.P.J.G.

AU - van Roon, J.A.G.

PY - 2009/9/1

Y1 - 2009/9/1

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Immunology

KW - Pharmacology

KW - Overig medisch onderzoek

M3 - Patent

M1 - 61/238694

ER -